Avidity Biosciences Inc. (RNA) Fundamentals

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
SHARE INFORMATION
Market Cap$ 547,892,931
Shares Outstanding54,462,518
Float45,453,515
Percent Float83.46%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 9,326,000
Latest Fiscal EPS$ -2.86
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions292
Institutional Holdings Date2022-11-30
Institutional Bought Previous 3 Months4,226,984
Institutional Holdings Percent153.0%
Institutional Sold Previous 3 Months6,790,260
Insider Holdings Date2022-11-30
Insider Bought Previous 3 Months80,000
Insider Holdings Percent0.2
Insider Sold Previous 3 Months160,000
Insider Shares Owned90,948
TRADING INFO
52 Week High$ 27.00
52 Week Low$ 9.89
52 Week High Change$ -59.63
21 Day Moving Average$ 12.5933
21 Day Extended Moving Average$ 12.3969
50 Day Moving Average$ 14.2144
50 Day Extended Moving Average$ 14.1237
200 Day Moving Average$ 16.3575
200 Day Extended Moving Average$ 16.7865
10 Day Average Volume728,113
20 Day Average Volume664,070
30 Day Average Volume652,983
50 Day Average Volume643,157
Alpha-0.029032
Beta0.7051
Standard Deviation0.131606
R20.085965
7 Day Price Change$ -1.49
7 Day Percent Change-12.9%
21 Day Price Change$ -4.24
21 Day Percent Change-29.65%
30 Day Price Change$ -3.50
30 Day Percent Change-25.81%
Month to Date Price Change$ -1.58
Month to Date Percent Change-13.57%
Quarter to Date Price Change$ -6.27
Quarter to Date Percent Change-38.4%
180 Day Price Change$ -2.59
180 Day Percent Change-20.47%
200 Day Price Change$ -2.89
200 Day Percent Change-22.32%
Year to Date Price Change$ -13.71
Year to Date Percent Change-57.68%

Avidity Biosciences Inc. (RNA) Key Ratios

PROFITABILITY
EBIT Margin-1,976.6%
EBITDA Margin-1,961.9%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 8,307,000
Revenue Per Share$ 0.1525
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book1.60
Total Debt To Equity0.00
Int Coverage-473.20
Current Ratio9.70
Leverage Ratio1.10
Quick Ratio9.50
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-3.40
Enterprise Value$ 214,617,951
Price to Sales65.9556
Price to Free Cash-4.80
PE High Last 5 Years0.00
Price To Book1.60
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book1.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-37.84
Return on Equity-41.99
Return on Capital-41.75

Avidity Biosciences Inc. (RNA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorBDO USA, LLP
CEOSarah Boyce
Emplyoees125
Last AuditUQ
CIK0001599901
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address10578 Science Center Drive
Suite 125
San Diego, CA 92121
Websitehttps://www.aviditybiosciences.com
Facsimile-
Telephone+1 858 401-7900
Email-


Your Recent History
NASDAQ
RNA
Avidity Bi..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.